Researchers explored alterations in PREEMPT protocol and the explanations for them using an anonymous questionnaire to headache clinicians.
Researchers assessed whether exposure to repetitive head impacts during a professional football career was associated with an increased in the risk for all-cause mortality.
The FDA has approved solifenacin succinate LS oral suspension for the treatment of neurogenic detrusor overactivity in pediatric patients 2 years of age and older.
Digital CBT involved 6 weekly remote sessions via website or iOS app lasting approximately 20 minutes and comprised sleep restriction, stimulus control, relaxation techniques, cognitive therapy, and sleep hygiene and education.
Higher cardiovascular risk burden assessed by the Framingham General Cardiovascular Risk Score is associated with cognitive decline and structural brain differences.
Migraine attacks were more frequent in post-pubertal compared to pre-pubertal girls, with no observed difference in headache characteristics between the groups.
The FDA has granted Fast Track designation to arimoclomol (Orphazyme A/S) for the treatment of amyotrophic lateral sclerosis.
The lipid profiles for asymptomatic intracranial arterial stenosis among rural residents in China were found to be characterized by high atherogenic cholesterol, low antiatherogenic cholesterol, and high ratios of atherogenic-to-antiatherogenic cholesterol or lipoproteins.
Excess mortality occurred as the result of a number of causes, including overdose, injuries, and both infectious and noncommunicable diseases.
Sleep-onset problems in the first year of life may precede an autism spectrum disorder diagnosis in children at higher risk for autism spectrum disorder.